CVS Pharmacy emblem is seen in Washington DC, United States on July 9, 2024.
Jakub Porzycki | Nurphoto | Getty Photographs
CVS Well being‘s board has engaged advisors to conduct a strategic overview of its enterprise, in response to folks accustomed to the matter, as the corporate contends with potential activist strain and a severely depressed inventory worth.
The overview has been ongoing for a while, mentioned the folks, however there is no such thing as a certainty on what actions, if any, the corporate will take.
CVS administration, together with CEO Karen Lynch, met with main shareholder Glenview Capital Monday to debate the corporate’s lagging prospects and Glenview’s plans to revive the inventory, CNBC beforehand reported.
However Lynch has to deal with an insurance coverage enterprise hammered by heightened medical prices.
In an announcement, CVS spokesman David Whitrap advised CNBC: “CVS Well being’s administration crew and Board of Administrators are regularly exploring methods to create shareholder worth. We stay targeted on driving efficiency and delivering prime quality healthcare services enabled by our unmatched scale and built-in mannequin.”
The corporate has additionally grappled with management turnover. Lynch assumed direct management of CVS’s insurance coverage unit earlier this yr, displacing then-president Brian Kane.
CVS shares rose round 2.5% in after-hours buying and selling Monday on the information, which was first reported by Reuters.
— CNBC’s Bertha Coombs contributed to this story
